Search for Clinical Trial Results
Long QT Syndrome - 35 Studies Found
Status | Study |
Completed |
Study Name: Study of the Effect of GS-6615 in Subjects With LQT-3 Condition: Long QT Syndrome Date: 2013-05-06 Interventions: Drug: GS-6615 GS-6615 tablet(s) administered orally |
Recruiting |
Study Name: Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients Condition: Long QT Syndrome Type 1 or 2 Date: 2012-12-05 Interventions:
|
Completed |
Study Name: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Condition: Long QT Syndrome Date: 2015-03-11 Interventions: Drug: Eleclazine Eleclazine tablets administered orally |
Recruiting |
Study Name: Efficacy Study of Sodium Channel Blocker in LQT3 Patients Condition: Long QT Syndrome Date: 2012-07-18 Interventions:
|
Recruiting |
Study Name: Long QT and Hearing Loss Registry Condition:
Date: 2014-03-06 |
Recruiting |
Study Name: Genetics of QT Prolongation With Antiarrhythmics Condition:
Date: 2015-05-05 Interventions: Drug: Dofetilide and/or sotalol This is an observational study of patients receiving Dofetilide and/or s |
Active, not recruiting |
Study Name: Metabolism of Patients With Genetically Caused Cardiac Arrhythmia Condition: Long QT Syndrome Date: 2016-03-16 |
Completed |
Study Name: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function Condition: Long QT Syndrome Date: 2015-05-08 Interventions: Drug: Eleclazine Eleclazine tablets administered orally in morning with food |
Completed |
Study Name: QT-prolongation in Psychiatric Hospitals Condition: QT-prolongation Date: 2014-01-21 Interventions: Drug: drugs linked with QT-prolongation all the drugs that are mentioned in the lists of QT-prolonging d |
Completed |
Study Name: Drug Interactions With Risk of QT-prolongation in a General Hospital Condition: QT-prolongation Date: 2014-01-21 Interventions: Drug: Haloperidol Other Name: Haldol |